The World Influenza Congress Europe 2011 - Sponsor list

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company’s proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license ...

Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. In 2009 alone, Crucell distributed more than 115 million vaccine doses in more than 100 countries around the world, with the vast majority of doses (97%)...

Immune Targeting Systems (ITS) is a London based biotech company developing vaccines for mutating viruses underpinned by its DepoVaccine and High Density Antigen identification technology platforms. ITS’s lead program is a synthetic universal influenza vaccine targeting all potential seasonal and pandemic flu strains. A clinical trial application was submitted to the UK MHRA in July 2010 and...

AVIR Green Hills Biotechnology is a clinical stage vaccine company that develops vaccines against influenza, tuberculosis and cervical cancer. The lead product is deltaFLU a novel intranasal influenza vaccine. deltaFLU induces both, local and systemic immune responses and is currently tested in phase II trials.